5,6-dihydroxytryptamine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, A; Carta, M; Garcia, J; Shin, E; Winkler, C | 1 |
| Jonsson, G | 1 |
1 review(s) available for 5,6-dihydroxytryptamine and Parkinson Disease
| Article | Year |
|---|---|
Chemical neurotoxins as denervation tools in neurobiology.
Topics: 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Animals; Benzylamines; Brain; Catecholamines; Denervation; Dopamine; Glutamates; Humans; Hydroxydopamines; Ibotenic Acid; Kainic Acid; Neurotoxins; Neurotransmitter Agents; p-Chloroamphetamine; Parkinson Disease; Rats; Receptors, Neurotransmitter; Schizophrenia; Serotonin | 1980 |
1 other study(ies) available for 5,6-dihydroxytryptamine and Parkinson Disease
| Article | Year |
|---|---|
Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
Topics: 5,6-Dihydroxytryptamine; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Buspirone; Cell Count; Creatinine; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Motor Activity; Oxidopamine; Parkinson Disease; Pyridines; Rats; Rats, Sprague-Dawley; Serotonergic Neurons; Serotonin Receptor Agonists; Time Factors | 2012 |